{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:22:53Z","timestamp":1783354973481,"version":"3.54.6"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018012","name":"Rashtrasant Tukadoji Maharaj Nagpur University","doi-asserted-by":"publisher","award":["RTMNU\/RDC\/2024\/146"],"award-info":[{"award-number":["RTMNU\/RDC\/2024\/146"]}],"id":[{"id":"10.13039\/100018012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbr.2025.115793","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T06:48:28Z","timestamp":1756968508000},"page":"115793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Therapeutic potential of agmatine in alcohol use disorder: Preclinical insights and future directions"],"prefix":"10.1016","volume":"495","author":[{"given":"Poonam","family":"Dhaigude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Pable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Katariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Tadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Umekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandkishor","family":"Kotagale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2025.115793_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainresbull.2020.11.015","article-title":"Agmatine improves the behavioral and cognitive impairments associated with chronic gestational ethanol exposure in rats","volume":"167","author":"Aglawe","year":"2021","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.bbr.2025.115793_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/fcp.12034","article-title":"Participation of central imidazoline binding sites in antinociceptive effect of ethanol and nicotine in rats","volume":"28","author":"Aglawe","year":"2014","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbr.2025.115793_bib3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0166-2236(02)02254-3","article-title":"cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO","volume":"25","author":"Ahern","year":"2002","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00726-019-02720-7","article-title":"The therapeutic and nutraceutical potential of agmatine, and its enhanced production using aspergillus oryzae","volume":"52","author":"Akasaka","year":"2019","journal-title":"Amino Acids"},{"issue":"4","key":"10.1016\/j.bbr.2025.115793_bib5","first-page":"461","volume":"83","author":"Bahji","year":"2022","journal-title":"Neurobiol. Symptomatology PostAcute Alcohol Withdrawal A MixedStud. Syst. Rev."},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/157488912800673128","article-title":"Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence","volume":"7","author":"Barron","year":"2012","journal-title":"Recent Pat. CNS Drug Discov."},{"issue":"4","key":"10.1016\/j.bbr.2025.115793_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11064-018-02712-1","article-title":"Therapeutic effect of agmatine on neurological disease: focus on ion channels and receptors","volume":"44","author":"Barua","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2025.115793_bib8","first-page":"2320","article-title":"Agmatine a novel neurotransmitter: a general review","volume":"12","author":"Bawankar","year":"2024","journal-title":"Int. J. Creat. Res. Thoughts"},{"key":"10.1016\/j.bbr.2025.115793_bib9","first-page":"91","article-title":"Neurotransmitters","author":"Benarroch","year":"2008","journal-title":"Pharmacol. Ther. Princ. Pract."},{"key":"10.1016\/j.bbr.2025.115793_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.metabol.2017.11.005","article-title":"Metabolic strategies for the degradation of the neuromodulator agmatine in mammals","volume":"81","author":"Ben\u00edtez","year":"2018","journal-title":"Metab. Clin. Exp."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-49078-0","article-title":"Safety and neurochemical profiles of acute and sub-chronic oral treatment with agmatine sulfate","volume":"9","author":"Bergin","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pharmthera.2010.09.007","article-title":"Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse","volume":"129","author":"Breese","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bbr.2025.115793_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40265-021-01670-3","article-title":"Novel agents for the pharmacological treatment of alcohol use disorder","volume":"82","author":"Burnette","year":"2022","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.bbr.2025.115793_bib14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s40263-017-0463-7","article-title":"The role of GABA receptor agonists in anesthesia and sedation","volume":"31","author":"Brohan","year":"2017","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.bbr.2025.115793_bib15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1042\/BST0351119","article-title":"Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase","volume":"35","author":"Brown","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbr.2025.115793_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neubiorev.2019.05.014","article-title":"Building better strategies to develop new medications in alcohol use disorder: learning from past success and failure to shape a brighter future","volume":"103","author":"Cannella","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2025.115793_bib17","unstructured":"Canver, B.R., Newman, R.K., & Gomez, A.E. (2024). Alcohol Withdrawal Syndrome. StatPearls. \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441882\/\u3009."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4331\/wjbc.v13.i1.15","article-title":"Increased monoamine oxidase activity and imidazoline binding sites in insulin-resistant adipocytes from obese zucker rats","volume":"13","author":"Carpene","year":"2022","journal-title":"World J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbr.2025.115793_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14030294","article-title":"A narrative review of current and emerging trends in the treatment of alcohol use disorder","volume":"14","author":"Celik","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbr.2025.115793_bib20","doi-asserted-by":"crossref","unstructured":"Chandurkar, P.A., Kale, M.B., Aglawe, M.M., Rahangdale, S.S., Umekar, M.J., & Taksande, B.G. (2023). Potential of Agmatine as a New Neuroprotective Molecule in Brain Disorders. https:\/\/doi.org\/10.36922\/itps.370.","DOI":"10.36922\/itps.370"},{"issue":"9","key":"10.1016\/j.bbr.2025.115793_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163634","article-title":"Agmatine reduces lipopolysaccharide-mediated oxidant response via activating PI3K\/Akt pathway and up-regulating Nrf2 and HO-1 expression in macrophages","volume":"11","author":"Chai","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.bbr.2025.115793_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.alcohol.2019.09.002","article-title":"Inhibitory influence of agmatine in ethanol withdrawal-induced depression in rats: behavioral and neurochemical evidence","volume":"83","author":"Chimthanawala","year":"2020","journal-title":"Alcohol"},{"issue":"4","key":"10.1016\/j.bbr.2025.115793_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cld.2024.06.006","article-title":"Epidemiology and health care burden of alcohol use disorder","volume":"28","author":"Choi","year":"2024","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.bbr.2025.115793_bib24","first-page":"310","article-title":"How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective","volume":"31","author":"Clapp","year":"2008","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.bbr.2025.115793_bib25","unstructured":"Clements, B.M., Advisor, D., & Fairbanks, C.A. (2022). Pharmacokinetics and pharmacodynamics of strategically substituted agmatines a dissertation submitted to the faculty of the university of minnesota."},{"issue":"3","key":"10.1016\/j.bbr.2025.115793_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.123.001828","article-title":"Biodistribution of agmatine to brain and spinal cord after systemic delivery","volume":"387","author":"Clements","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF02255966","article-title":"Role of glutamatergic and GABAergic systems in alcoholism","volume":"8","author":"Davis","year":"2001","journal-title":"J. Biomed. Sci."},{"issue":"7","key":"10.1016\/j.bbr.2025.115793_bib28","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.addbeh.2004.06.020","article-title":"Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol","volume":"29","author":"De Witte","year":"2004","journal-title":"Addict. Behav."},{"issue":"5","key":"10.1016\/j.bbr.2025.115793_bib29","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jnc.15343","article-title":"Neurobiology of alcohol seeking behavior","volume":"157","author":"Domi","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2025.115793_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-981-10-7757-9_5","article-title":"Monoamine oxidases","volume":"87","author":"Edmondson","year":"2018","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbr.2025.115793_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.etap.2017.08.009","article-title":"The inhibition of inducible nitric oxide synthase and oxidative stress by agmatine attenuates vascular dysfunction in rat acute endotoxemic model","volume":"55","author":"El-Awady","year":"2017","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.bbr.2025.115793_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173155","article-title":"Tolerance to alcohol: a critical yet understudied factor in alcohol addiction","volume":"204","author":"Elvig","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2025.115793_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.927703","article-title":"Off-label and investigational drugs in the treatment of alcohol use disorder: a critical review","volume":"13","author":"Fischler","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2025.115793_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-981-19-7122-8_7","article-title":"Neurotransmitters","author":"Gao","year":"2022","journal-title":"Biol. Vasc. Smooth Muscle"},{"issue":"7","key":"10.1016\/j.bbr.2025.115793_bib35","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/01.ALC.0000075824.10502.DD","article-title":"Polyamines contribute to ethanol withdrawal-induced neurotoxicity in rat hippocampal slice cultures through interactions with the NMDA receptor","volume":"27","author":"Gibson","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.bbr.2025.115793_bib36","article-title":"Evidence for safety of the dietary ingredient agmatine sulfate as assessed by mutagenicity and genotoxicity studies","volume":"13","author":"Gilad","year":"2024","journal-title":"Toxicol. Rep."},{"issue":"1\u20133","key":"10.1016\/j.bbr.2025.115793_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2006.08.057","article-title":"Anxiolytic effect of agmatine in rats and mice","volume":"550","author":"Gong","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2025.115793_bib38","unstructured":"Haddjeri, Nasser., & Haddjeri, Nasser. (1997). Auto- and heteromodulation of the rat brain 5-HT system: involvement in the mechanism of action of antidepressant drugs. McGill University. \u3008https:\/\/escholarship.mcgill.ca\/concern\/theses\/bc386m17f?locale=en\u3009."},{"issue":"11","key":"10.1016\/j.bbr.2025.115793_bib39","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine: metabolic pathway and spectrum of activity in brain","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.bbr.2025.115793_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.5530\/ijpi.14.3.78","article-title":"Agmatine as a promising neuroprotective strategy for treating neurological disorders","volume":"14","author":"Harish","year":"2024","journal-title":"Int. J. Pharm. Investig."},{"issue":"15","key":"10.1016\/j.bbr.2025.115793_bib41","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2174\/1389557523666230125104753","article-title":"Perspectives on agmatine neurotransmission in acute and chronic stressrelated conditions","volume":"23","author":"Hassanshahi","year":"2023","journal-title":"MiniRev. Med. Chem."},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1369-1600.2009.00194.x","article-title":"Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?","volume":"15","author":"Heilig","year":"2010","journal-title":"Addict. Biol."},{"key":"10.1016\/j.bbr.2025.115793_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102482","article-title":"Imidazoline receptors as a new therapeutic target in Huntington\u2019s disease: a preclinical overview","volume":"101","author":"Jari","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"22","key":"10.1016\/j.bbr.2025.115793_bib44","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1523\/JNEUROSCI.3845-16.2017","article-title":"Dopamine receptors differentially control binge alcohol Drinking-Mediated synaptic plasticity of the core nucleus accumbens direct and indirect pathways","volume":"37","author":"Ji","year":"2017","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2025.115793_bib45","doi-asserted-by":"crossref","first-page":"670","DOI":"10.5530\/ijpi.14.3.78","article-title":"Agmatine as a promising neuroprotective strategy for treating neurological disorders","volume":"14","author":"K. H., H","year":"2024","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.bbr.2025.115793_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137804","article-title":"Agmatine alleviates ethanol withdrawal-associated cognitive impairment and neurochemical imbalance in rats","volume":"832","author":"Kale","year":"2024","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bcp.12070","article-title":"The clinical pharmacology of acamprosate","volume":"77","author":"Kalk","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib48","article-title":"Alcohol use disorder and depressive disorders","volume":"40","author":"Kathryn Mchugh","year":"2019","journal-title":"Alcohol Res. Curr. Rev."},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib49","first-page":"3","article-title":"The serotonin link between alcohol use and affective disorders","volume":"1","author":"Ketcherside","year":"2013","journal-title":"J. Addict. Prev."},{"issue":"3","key":"10.1016\/j.bbr.2025.115793_bib50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1526-4637.2010.00808.x","article-title":"Safety and efficacy of dietary agmatine sulfate in lumbar disc-associated radiculopathy. An open-label, dose-escalating study followed by a randomized, double-blind, placebo-controlled trial","volume":"11","author":"Keynan","year":"2010","journal-title":"Pain. Med."},{"issue":"6","key":"10.1016\/j.bbr.2025.115793_bib51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5607\/en.2017.26.6.380","article-title":"Endogenous agmatine induced by ischemic preconditioning regulates ischemic tolerance following cerebral ischemia","volume":"26","author":"Kim","year":"2017","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.bbr.2025.115793_bib52","first-page":"3","author":"Koob","year":"2011","journal-title":"Theor. Framew. Mech. Asp. Alcohol Addict. Alcohol Addict. a Reward Deficit Disord."},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5115\/acb.21.089","article-title":"Role of agmatine in the application of neural progenitor cell in central nervous system diseases: therapeutic potentials and effects","volume":"54","author":"Kosonen","year":"2021","journal-title":"Anat. Cell Biol."},{"key":"10.1016\/j.bbr.2025.115793_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.alcohol.2022.02.004","article-title":"Agmatine prevents development of tolerance to anti-nociceptive effect of ethanol in mice","volume":"101","author":"Kotagale","year":"2022","journal-title":"Alcohol"},{"issue":"8","key":"10.1016\/j.bbr.2025.115793_bib55","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1176\/appi.ajp.20230488","article-title":"Overview of alcohol use disorder","volume":"180","author":"Kranzler","year":"2023","journal-title":"Am. J. Psychiatry"},{"issue":"15","key":"10.1016\/j.bbr.2025.115793_bib56","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1042\/BCJ20170007","article-title":"Agmatine: multifunctional arginine metabolite and magic bullet in clinical neuroscience?","volume":"474","author":"Laube","year":"2017","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib57","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pbb.2007.07.012","article-title":"Agmatine reduces balance deficits in a rat model of third trimester Binge-Like ethanol exposure","volume":"88","author":"Lewis","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2025.115793_bib58","unstructured":"Lewis, J.Ben. (2011). Polyamine modulation in alcoholism: examination using a novel screening procedure designed to predict anti-relapse and neuroprotective efficacy. \u3008http:\/\/uknowledge.uky.edu\/gradschool_diss\/851\u3009."},{"issue":"8","key":"10.1016\/j.bbr.2025.115793_bib59","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/aps.2014.50","article-title":"Alcohol use disorders and current pharmacological therapies: the role of GABAA receptors","volume":"35","author":"Liang","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.bbr.2025.115793_bib60","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hipo.20482","article-title":"Spatial learning results in elevated agmatine levels in the rat brain","volume":"18","author":"Liu","year":"2008","journal-title":"Hippocampus"},{"key":"10.1016\/j.bbr.2025.115793_bib61","doi-asserted-by":"crossref","first-page":"1364858","DOI":"10.3389\/fpsyt.2024.1364858","article-title":"Insights into the structure and function of the hippocampus: implications for the pathophysiology and treatment of autism spectrum disorder","volume":"15","author":"Long","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2025.115793_bib62","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.4201510","article-title":"Agmatine reduces alcohol drinking and alleviates hyperalgesia symptoms in rodent models of alcohol use disorder","author":"Lopez","year":"2022","journal-title":"SSRN Electron. J."},{"key":"10.1016\/j.bbr.2025.115793_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.alcohol.2023.01.003","article-title":"Agmatine reduces alcohol drinking and produces antinociceptive effects in rodent models of alcohol use disorder","volume":"109","author":"Lopez","year":"2023","journal-title":"Alcohol"},{"issue":"5","key":"10.1016\/j.bbr.2025.115793_bib64","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/ajad.13455","article-title":"Medication treatment for alcohol use disorder in special populations","volume":"32","author":"Malhotra","year":"2023","journal-title":"Am. J. Addict."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-2-20","article-title":"Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration","volume":"2","author":"Mander","year":"2005","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib66","doi-asserted-by":"crossref","DOI":"10.35946\/arcr.v41.1.07","article-title":"Alcohol use disorder: the role of medication in recovery","volume":"41","author":"Mason","year":"2021","journal-title":"Alcohol Res. Curr. Rev."},{"key":"10.1016\/j.bbr.2025.115793_bib67","unstructured":"McNeely, J., Hamilton, L.K., Whitley, S.D., Wiegand, T.J., Stancliff, S.L., Norton, B.L., Gonzalez, C.J., & Hoffman, C.J. (2024). Substance use screening, risk assessment, and use disorder diagnosis in adults. substance use screening, risk assessment, and use disorder diagnosis in adults. \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK565474\/\u3009."},{"issue":"1\u20133","key":"10.1016\/j.bbr.2025.115793_bib68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","article-title":"Excitotoxicity: bridge to various triggers in neurodegenerative disorders","volume":"698","author":"Mehta","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2025.115793_bib69","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pharmthera.2011.12.005","article-title":"Agmatine (decarboxylated l-arginine): physiological role and therapeutic potential","volume":"133","author":"Molderings","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbr.2025.115793_bib70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-012370420-7\/50012-5","article-title":"Regulation of arginine availability and its impact on NO synthesis","author":"Morris","year":"2000","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/157015908783769662","article-title":"Alcohol related changes in regulation of NMDA receptor functions","volume":"6","author":"Nagy","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbr.2025.115793_bib72","first-page":"1","author":"Nehring","year":"2024","journal-title":"Alcohol use disord. instant wisdom gps pearls all spec. second ed."},{"issue":"4","key":"10.1016\/j.bbr.2025.115793_bib73","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/1386207311316040004","article-title":"Imidazoline-1 receptor ligands as apoptotic agents: pharmacophore modeling and virtual docking study","volume":"16","author":"Nikolic","year":"2013","journal-title":"Comb. Chem. High. Throughput Screen."},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib74","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0733-8627(05)70124-3","article-title":"Withdrawal syndromes","volume":"18","author":"Olmedo","year":"2000","journal-title":"Emerg. Med. Clin. North Am."},{"issue":"7","key":"10.1016\/j.bbr.2025.115793_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073087","article-title":"Agmatine enhances dorsal raphe serotonergic neuronal activity via dual regulation of 5-HT1B and 5-HT2A receptors","volume":"26","author":"Ozba\u015fak","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib76","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2011.03.010","article-title":"Agmatine blocks ethanol-induced locomotor hyperactivity in Male mice","volume":"659","author":"Ozden","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib77","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2007.04.050","article-title":"Anti-hypernociceptive properties of agmatine in persistent inflammatory and neuropathic models of pain in mice","volume":"1159","author":"Paszcuk","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2025.115793_bib78","unstructured":"Peterson, C.D., Fairbanks, C.A., & Wilcox, G.L. (2017). Alleviation of chronic neuropathic pain by agmatine requires the glun2b subunit of the nmda receptor a thesis submitted to the faculty of university of minnesota by."},{"issue":"8","key":"10.1016\/j.bbr.2025.115793_bib79","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/biology10080723","article-title":"Hypoxia signaling in Parkinson\u2019s disease: there is use in asking \u201cWhat HIF?\u201d","volume":"10","author":"Pinilla","year":"2021","journal-title":"Biology"},{"issue":"10","key":"10.1016\/j.bbr.2025.115793_bib80","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.gastrohep.2017.05.011","article-title":"Neurological manifestations of excessive alcohol consumption","volume":"40","author":"Planas-Ballv\u00e9","year":"2017","journal-title":"Gastroenterol. \u00eda Y. Hepatol. \u00eda (Engl. Ed. )"},{"key":"10.1016\/j.bbr.2025.115793_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.115173","article-title":"Targeting NMDA receptors with an antagonist is a promising therapeutic strategy for treating neurological disorders","volume":"472","author":"Rafe","year":"2024","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib82","first-page":"1","article-title":"Antagonization of monoamine reuptake transporters by agmatine improves anxiolytic and locomotive behaviors commensurate with fluoxetine and methylphenidate","volume":"10","author":"Rafi","year":"2021","journal-title":"BeniSuef Univ. J. Basic Appl. Sci."},{"key":"10.1016\/j.bbr.2025.115793_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2024.102429","article-title":"Pharmacological profile of agmatine: an in-depth overview","volume":"105","author":"Rafi","year":"2024","journal-title":"Neuropeptides"},{"issue":"5","key":"10.1016\/j.bbr.2025.115793_bib84","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.phrs.2003.10.008","article-title":"Vascular regulation by the l-arginine metabolites, nitric oxide and agmatine","volume":"49","author":"Raghavan","year":"2004","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib85","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American psychiatric association practice guideline for the pharmacological treatment of patients with alcohol use disorder","volume":"175","author":"Reus","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbr.2025.115793_bib86","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/alcalc\/agz067","article-title":"From pleasure to pain, and back again: the intricate relationship between alcohol and nociception","volume":"54","author":"Robins","year":"2019","journal-title":"Alcohol. Alcohol. (Oxf. Oxfs. )"},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib87","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/nu12020576","article-title":"Evidence for dietary agmatine sulfate effectiveness in neuropathies associated with painful small fiber neuropathy. A pilot Open-Label consecutive case series study","volume":"12","author":"Rosenberg","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FBP.0b013e32835efc46","article-title":"Agmatine attenuates acquisition but not the expression of ethanol conditioned place preference in mice: a role for imidazoline receptors","volume":"24","author":"Sameer","year":"2013","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1304.004","article-title":"Agmatine: at the crossroads of the arginine pathways","volume":"1009","author":"Satriano","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bbr.2025.115793_bib90","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00726-004-0078-4","article-title":"Arginine pathways and the inflammatory responses: interregulation of nitric oxide and polyamines. Review article","volume":"26","author":"Satriano","year":"2004","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbr.2025.115793_bib91","first-page":"1","article-title":"Stress - from molecules to behavior: a comprehensive analysis of the neurobiology of stress responses","author":"Soreq","year":"2009","journal-title":"Stress Mol. Behav. A Compr. Anal. Neurobiol. Stress Responses"},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib92","doi-asserted-by":"crossref","DOI":"10.1080\/14656566.2024.2445734","article-title":"Modern pharmacotherapy guidance for treating alcohol use disorders","volume":"26","author":"Soyka","year":"2025","journal-title":"Expert Opin. Pharmacother."},{"issue":"1\u20133","key":"10.1016\/j.bbr.2025.115793_bib93","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2008.11.062","article-title":"Preventive mechanisms of agmatine against ischemic acute kidney injury in rats","volume":"603","author":"Sugiura","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2025.115793_bib94","unstructured":"Sun, Z., & Ernsberger, P. (2007). Imidazoline receptors in insulin signaling and metabolic regulation."},{"issue":"4","key":"10.1016\/j.bbr.2025.115793_bib95","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/acer.13972","article-title":"Agmatine inhibits behavioral sensitization to ethanol through imidazoline receptors","volume":"43","author":"Taksande","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1\u20133","key":"10.1016\/j.bbr.2025.115793_bib96","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2010.03.058","article-title":"Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats","volume":"637","author":"Taksande","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2025.115793_bib97","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2009.06.035","article-title":"Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine","volume":"57","author":"Taksande","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2025.115793_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172779","article-title":"Agmatine reverses ethanol consumption in rats: evidences for an interaction with imidazoline receptors","volume":"186","author":"Taksande","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2025.115793_bib99","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopha.2017.07.004","article-title":"Acute orexigenic effect of agmatine involves interaction between central \u03b12-adrenergic and GABAergic receptors","volume":"93","author":"Taksande","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bbr.2025.115793_bib100","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.euroneuro.2013.12.002","article-title":"Neuropeptide y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats","volume":"24","author":"Taksande","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"31","key":"10.1016\/j.bbr.2025.115793_bib101","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1523\/JNEUROSCI.2157-21.2022","article-title":"Blunted expected reward value signals in binge alcohol drinkers","volume":"43","author":"Tolomeo","year":"2023","journal-title":"J. Neurosci."},{"issue":"30","key":"10.1016\/j.bbr.2025.115793_bib102","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.2174\/092986712803530601","article-title":"A new target for diagnosis and treatment of CNS disorders: agmatinergic system","volume":"19","author":"Uzbay","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib103","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.neubiorev.2011.08.006","article-title":"The pharmacological importance of agmatine in the brain","volume":"36","author":"Uzbay","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1\u20133","key":"10.1016\/j.bbr.2025.115793_bib104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2009.12.020","article-title":"Sex-related effects of agmatine on caffeine-induced locomotor activity in Swiss webster mice","volume":"630","author":"Uzbay","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2025.115793_bib105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0166-4328(99)00127-8","article-title":"Effects of agmatine on ethanol withdrawal syndrome in rats","volume":"107","author":"Uzbay","year":"2000","journal-title":"Behav. Brain Res."},{"issue":"11","key":"10.1016\/j.bbr.2025.115793_bib106","doi-asserted-by":"crossref","first-page":"981","DOI":"10.5498\/wjp.v11.i11.981","article-title":"Agmatine as a novel candidate for rapid-onset antidepressant response","volume":"11","author":"Valverde","year":"2021","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.bbr.2025.115793_bib107","series-title":"Alcohol and Alcohol-Related Diseases","first-page":"687","article-title":"Alcohol use disorder: stress, negative reinforcement, and negative urgency","author":"Vendruscolo","year":"2023"},{"issue":"2","key":"10.1016\/j.bbr.2025.115793_bib108","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1152\/jn.00172.2018","article-title":"Agmatine preferentially antagonizes GluN2B-containing N-methyl-D-aspartate receptors in spinal cord","volume":"121","author":"Waataja","year":"2019","journal-title":"J. Neurophysiol."},{"issue":"3","key":"10.1016\/j.bbr.2025.115793_bib109","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/ijms24031819","article-title":"Autism spectrum disorder: neurodevelopmental risk factors, biological mechanism, and precision therapy","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2025.115793_bib110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejphar.2010.09.071","article-title":"Agmatine modulates neuroadaptations of glutamate transmission in the nucleus accumbens of repeated morphine-treated rats","volume":"650","author":"Wang","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2025.115793_bib111","unstructured":"Winter, T.N. (2011). Identification and characterization of carrier transport systems influencing agmatine disposition."},{"key":"10.1016\/j.bbr.2025.115793_bib112","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-psych-010418-103337","article-title":"Dopamine and addiction","volume":"71","author":"Wise","year":"2020","journal-title":"Annu. Rev. Psychol."},{"issue":"5","key":"10.1016\/j.bbr.2025.115793_bib113","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10571-007-9164-y","article-title":"Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence","volume":"28","author":"Wu","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2025.115793_bib114","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.122.177710","article-title":"Agmatine inhibits NMDA Receptor-mediated calcium transients in spinal cord dorsal horn","volume":"385","author":"Xie","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.bbr.2025.115793_bib115","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.2174\/1570159X15666170808120633","article-title":"Neuroprotective role of agmatine in neurological diseases","volume":"16","author":"Xu","year":"2017","journal-title":"Curr. Neuropharmacol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825003808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825003808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:27:39Z","timestamp":1772832459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432825003808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":115,"alternative-id":["S0166432825003808"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115793","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of agmatine in alcohol use disorder: Preclinical insights and future directions","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115793"}}